PL2991983T3 - Pochodne 2-fenylo lub 2-hetaryloimidazolo[1,2-a]pirydyny - Google Patents

Pochodne 2-fenylo lub 2-hetaryloimidazolo[1,2-a]pirydyny

Info

Publication number
PL2991983T3
PL2991983T3 PL14719326T PL14719326T PL2991983T3 PL 2991983 T3 PL2991983 T3 PL 2991983T3 PL 14719326 T PL14719326 T PL 14719326T PL 14719326 T PL14719326 T PL 14719326T PL 2991983 T3 PL2991983 T3 PL 2991983T3
Authority
PL
Poland
Prior art keywords
hetaryl
imidazol
phenyl
pyridine derivatives
pyridine
Prior art date
Application number
PL14719326T
Other languages
English (en)
Inventor
Edilio Borroni
Luca Gobbi
Michael Honer
Henner Knust
Matthias Koerner
Dieter Muri
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL2991983T3 publication Critical patent/PL2991983T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14719326T 2013-04-29 2014-04-25 Pochodne 2-fenylo lub 2-hetaryloimidazolo[1,2-a]pirydyny PL2991983T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165676 2013-04-29
EP14719326.2A EP2991983B1 (en) 2013-04-29 2014-04-25 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives

Publications (1)

Publication Number Publication Date
PL2991983T3 true PL2991983T3 (pl) 2017-07-31

Family

ID=48190297

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14719326T PL2991983T3 (pl) 2013-04-29 2014-04-25 Pochodne 2-fenylo lub 2-hetaryloimidazolo[1,2-a]pirydyny

Country Status (18)

Country Link
US (3) US10138234B2 (pl)
EP (1) EP2991983B1 (pl)
JP (1) JP6212628B2 (pl)
KR (2) KR20160003173A (pl)
CN (1) CN105164125B (pl)
AR (1) AR096119A1 (pl)
AU (1) AU2014261628A1 (pl)
BR (1) BR112015027015A2 (pl)
CA (1) CA2910368A1 (pl)
DK (1) DK2991983T3 (pl)
ES (1) ES2624453T3 (pl)
MX (1) MX2015014353A (pl)
PL (1) PL2991983T3 (pl)
RU (1) RU2015147450A (pl)
SG (1) SG11201508912YA (pl)
SI (1) SI2991983T1 (pl)
WO (1) WO2014177458A1 (pl)
ZA (1) ZA201507389B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6212628B2 (ja) * 2013-04-29 2017-10-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 2−フェニル又は2−ヘタリールイミダゾール[1,2−a]ピリジン誘導体
SG11201509503QA (en) * 2013-05-23 2015-12-30 Hoffmann La Roche 2-phenylimidazo[1,2-a]pyrimidines as imaging agents
WO2015044095A1 (en) 2013-09-26 2015-04-02 F. Hoffmann-La Roche Ag Imidazo[1,2-a]pyridin-7-amines as imaging tools
BR112018006005A2 (pt) * 2015-09-29 2018-10-30 Oncotherapy Science Inc composto bicíclico e uso do mesmo para inibição de suv39h2
IL264239B (en) 2016-07-22 2022-08-01 Ac Immune Sa Compounds for imaging tau protein aggregates
JP7059270B2 (ja) 2016-07-22 2022-04-25 エーシー・イミューン・エス・アー タウタンパク質凝集体を画像化するための化合物
WO2018165112A1 (en) * 2017-03-09 2018-09-13 Oncotherapy Science, Inc. Bicyclic compound and use thereof for inhibiting histone methyltransferase
EP3743423A1 (en) 2018-01-24 2020-12-02 AC Immune SA Gamma-carboline compounds for the detection of tau aggregates
EP3743426A1 (en) 2018-01-24 2020-12-02 AC Immune SA Azacarboline compounds for the detection of tau aggregates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654436A (en) * 1995-06-07 1997-08-05 American Home Products Corporation 2-substituted benzimidazole derivatives
ES2274973T3 (es) * 2001-04-23 2007-06-01 The Trustees Of The University Of Pennsylvania Inhibidores de la agregacion de placas amiloides y agentes de obtencion de imagenes diagnosticas.
CN101003526B (zh) 2001-08-27 2012-02-22 宾夕法尼亚州大学理事会 茋衍生物及其用于结合和成像淀粉样蛋白斑的用途
EP1956013B1 (en) * 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
AU2007207053B2 (en) * 2006-01-17 2012-05-24 F. Hoffmann-La Roche Ag Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
US7700616B2 (en) * 2006-05-08 2010-04-20 Molecular Neuroimaging, Llc. Compounds and amyloid probes thereof for therapeutic and imaging uses
AU2007261985B2 (en) * 2006-06-21 2012-04-19 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
EP2098523A4 (en) * 2006-11-17 2011-09-21 Nihon Mediphysics Co Ltd NEW, AMYLOID-AFFINE COMPOUNDS
EP2125800A1 (en) * 2007-01-22 2009-12-02 AstraZeneca AB Novel heteroaryl substituted imidazo ý1,2 -a¨pyridine derivatives
US20150377123A1 (en) 2007-08-01 2015-12-31 United Technologies Corporation Turbine section of high bypass turbofan
EP2216052A4 (en) * 2007-10-30 2012-11-21 Nihon Mediphysics Co Ltd USE OF A NEW COMPOUND WITH AFFINITY FOR AMYLOID AND METHOD FOR THE PRODUCTION THEREOF
DK2338059T3 (en) 2008-09-23 2015-06-15 Wista Lab Ltd Ligands for aggregated tau molecules
PL2480546T3 (pl) * 2009-09-24 2015-05-29 Hoffmann La Roche Pochodne imidazopirydyny i imidazopirymidyny jako inhibitory fosfodiesterazy 10A
US8703768B2 (en) * 2010-06-09 2014-04-22 Hoffmann-La Roche Inc. Nitrogen containing heteroaryl compounds
JP6212628B2 (ja) 2013-04-29 2017-10-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 2−フェニル又は2−ヘタリールイミダゾール[1,2−a]ピリジン誘導体
WO2015044095A1 (en) * 2013-09-26 2015-04-02 F. Hoffmann-La Roche Ag Imidazo[1,2-a]pyridin-7-amines as imaging tools

Also Published As

Publication number Publication date
EP2991983A1 (en) 2016-03-09
US11358962B2 (en) 2022-06-14
RU2015147450A (ru) 2017-06-05
BR112015027015A2 (pt) 2017-07-25
ZA201507389B (en) 2017-01-25
JP2016520046A (ja) 2016-07-11
US20190048002A1 (en) 2019-02-14
KR20170094001A (ko) 2017-08-16
US20160244441A1 (en) 2016-08-25
HK1213555A1 (zh) 2016-07-08
US20190048003A1 (en) 2019-02-14
JP6212628B2 (ja) 2017-10-11
ES2624453T3 (es) 2017-07-14
CA2910368A1 (en) 2014-11-06
SI2991983T1 (sl) 2017-06-30
AR096119A1 (es) 2015-12-09
CN105164125A (zh) 2015-12-16
WO2014177458A1 (en) 2014-11-06
US10138234B2 (en) 2018-11-27
MX2015014353A (es) 2016-04-07
SG11201508912YA (en) 2015-11-27
DK2991983T3 (en) 2017-05-08
CN105164125B (zh) 2017-10-13
AU2014261628A1 (en) 2015-10-22
US10975073B2 (en) 2021-04-13
EP2991983B1 (en) 2017-03-01
KR20160003173A (ko) 2016-01-08

Similar Documents

Publication Publication Date Title
IL263404A (en) History of pyridyl bicyclic fused ring as fgfr4 inhibitors
IL240112B (en) A history of halogenated pyrazoles as pest control agents
ZA201507874B (en) 2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors
IL256898B (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
ZA201506570B (en) 2-phenylimidazo[1,2-a]pyrimidines as imaging agents
ZA201507389B (en) 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives
ZA201506747B (en) Imidazo pyridine compounds
IL240327B (en) New pyrazole derivatives
IL240496A0 (en) New derivatives of pyridine
ZA201507657B (en) Pyridin-4-yl derivatives
EP2970278A4 (en) Pyrrolo [2,3] PYRIDINE KINASE INHIBITORS CDK9-
IL244039A0 (en) Ethynyl derivatives
SG11201601135QA (en) 3-substituted cyclopentylamine derivatives
GB201300892D0 (en) Novel isothiazolo[4,3-b]pyridines
GB201314960D0 (en) Heterocyclic derivatives
GB201300306D0 (en) Heterocyclic derivatives